SEC Form 4 · accession 0000930413-18-002644
ENZO BIOCHEM INC · ENZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dov Perlysky
Director
Period of report
Apr 12, 2018
Accepted (ET)
Aug 20, 2018 · 4:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000316253
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Apr 12, 2018 | J | 3,139 | — | A | 697,837 | I | See Footnote |
| Common StockF1,F3 | Apr 13, 2018 | J | 81,855 | — | A | 779,692 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Engex, Inc., a closed-end mutual fund, liquidated and distributed, on a pro rata basis and without consideration, shares of Common Stock to its shareholders, among whom were Kinder Investment LP and Laya Perlysky (Mr. Perlysky's wife).
- F2Represents a distribution of shares of Common Stock by Engex, Inc. to Laya Perlysky, of which Dov Perlysky disclaims beneficial ownership.
- F3Represents a distribution of shares of Common Stock by Engex, Inc. to Kinder Investment LP, an entity of which Dov Perlysky is the Managing Member of the General Partner.